PN-1561

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePN-1561
Drug Alias NamePN-1561
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHematopoietic modulatorsBone modulators
TargetsUpdating
Therapy Area/IndicationsBone Marrow Failure DisordersSepsisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWellstat Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWellstat Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsBone Marrow Failure DisordersSepsisBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A